These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 30414342)

  • 1. Intestinal Immune Dysregulation Driven by Dysbiosis Promotes Barrier Disruption and Bacterial Translocation in Rats With Cirrhosis.
    Muñoz L; Borrero MJ; Úbeda M; Conde E; Del Campo R; Rodríguez-Serrano M; Lario M; Sánchez-Díaz AM; Pastor O; Díaz D; García-Bermejo L; Monserrat J; Álvarez-Mon M; Albillos A
    Hepatology; 2019 Sep; 70(3):925-938. PubMed ID: 30414342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between intestinal dendritic cells and bacteria translocated from the gut in rats with cirrhosis.
    Muñoz L; José Borrero M; Ubeda M; Lario M; Díaz D; Francés R; Monserrat J; Pastor O; Aguado-Fraile E; Such J; Alvarez-Mon M; Albillos A
    Hepatology; 2012 Nov; 56(5):1861-9. PubMed ID: 22611024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut-liver axis signaling in portal hypertension.
    Simbrunner B; Mandorfer M; Trauner M; Reiberger T
    World J Gastroenterol; 2019 Oct; 25(39):5897-5917. PubMed ID: 31660028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obeticholic acid reduces bacterial translocation and inhibits intestinal inflammation in cirrhotic rats.
    Úbeda M; Lario M; Muñoz L; Borrero MJ; Rodríguez-Serrano M; Sánchez-Díaz AM; Del Campo R; Lledó L; Pastor Ó; García-Bermejo L; Díaz D; Álvarez-Mon M; Albillos A
    J Hepatol; 2016 May; 64(5):1049-1057. PubMed ID: 26723896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of artesunate supplementation on bacterial translocation and dysbiosis of gut microbiota in rats with liver cirrhosis.
    Chen YX; Lai LN; Zhang HY; Bi YH; Meng L; Li XJ; Tian XX; Wang LM; Fan YM; Zhao ZF; Han DW; Ji C
    World J Gastroenterol; 2016 Mar; 22(10):2949-59. PubMed ID: 26973391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD.
    Pierantonelli I; Rychlicki C; Agostinelli L; Giordano DM; Gaggini M; Fraumene C; Saponaro C; Manghina V; Sartini L; Mingarelli E; Pinto C; Buzzigoli E; Trozzi L; Giordano A; Marzioni M; Minicis S; Uzzau S; Cinti S; Gastaldelli A; Svegliati-Baroni G
    Sci Rep; 2017 Sep; 7(1):12200. PubMed ID: 28939830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal, extra-intestinal and systemic sequelae of Toxoplasma gondii induced acute ileitis in mice harboring a human gut microbiota.
    von Klitzing E; Ekmekciu I; Kühl AA; Bereswill S; Heimesaat MM
    PLoS One; 2017; 12(4):e0176144. PubMed ID: 28414794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the gut-liver-immune axis to treat cirrhosis.
    Tranah TH; Edwards LA; Schnabl B; Shawcross DL
    Gut; 2021 May; 70(5):982-994. PubMed ID: 33060124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Commensal and Pathogenic Bacteria Indirectly Induce IL-22 but Not IFNγ Production From Human Colonic ILC3s via Multiple Mechanisms.
    Castleman MJ; Dillon SM; Purba CM; Cogswell AC; Kibbie JJ; McCarter MD; Santiago ML; Barker E; Wilson CC
    Front Immunol; 2019; 10():649. PubMed ID: 30984202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
    Stecher B
    Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of the Intestinal Microbiome and Gut Barrier to Hepatic Disorders.
    Chopyk DM; Grakoui A
    Gastroenterology; 2020 Sep; 159(3):849-863. PubMed ID: 32569766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant Gut Microbiome Contributes to Intestinal Oxidative Stress, Barrier Dysfunction, Inflammation and Systemic Autoimmune Responses in MRL/lpr Mice.
    Wang H; Wang G; Banerjee N; Liang Y; Du X; Boor PJ; Hoffman KL; Khan MF
    Front Immunol; 2021; 12():651191. PubMed ID: 33912174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacterial Translocation Is Linked to Increased Intestinal IFN-γ, IL-4, IL-17, and mucin-2 in Cholestatic Rats.
    Vega-Magaña N; Delgado-Rizo V; García-Benavides L; Del Toro-Arreola S; Segura-Ortega J; Morales ASMZ; Zepeda-Nuño JS; Escarra-Senmarti M; Gutiérrez-Franco J; Haramati J; Bueno-Topete MR
    Ann Hepatol; 2018 Mar; 17(2):318-329. PubMed ID: 29469038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploiting the Zonulin Mouse Model to Establish the Role of Primary Impaired Gut Barrier Function on Microbiota Composition and Immune Profiles.
    Miranda-Ribera A; Ennamorati M; Serena G; Cetinbas M; Lan J; Sadreyev RI; Jain N; Fasano A; Fiorentino M
    Front Immunol; 2019; 10():2233. PubMed ID: 31608059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigen-Specific Mucosal Immunity Regulates Development of Intestinal Bacteria-Mediated Diseases.
    Fujimoto K; Kawaguchi Y; Shimohigoshi M; Gotoh Y; Nakano Y; Usui Y; Hayashi T; Kimura Y; Uematsu M; Yamamoto T; Akeda Y; Rhee JH; Yuki Y; Ishii KJ; Crowe SE; Ernst PB; Kiyono H; Uematsu S
    Gastroenterology; 2019 Dec; 157(6):1530-1543.e4. PubMed ID: 31445037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacterial translocation in patients with liver cirrhosis: physiology, clinical consequences, and practical implications.
    Ponziani FR; Zocco MA; Cerrito L; Gasbarrini A; Pompili M
    Expert Rev Gastroenterol Hepatol; 2018 Jul; 12(7):641-656. PubMed ID: 29806487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential mechanisms linking gut microbiota and portal hypertension.
    Baffy G
    Liver Int; 2019 Apr; 39(4):598-609. PubMed ID: 30312513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Commensal microbiota affects ischemic stroke outcome by regulating intestinal γδ T cells.
    Benakis C; Brea D; Caballero S; Faraco G; Moore J; Murphy M; Sita G; Racchumi G; Ling L; Pamer EG; Iadecola C; Anrather J
    Nat Med; 2016 May; 22(5):516-23. PubMed ID: 27019327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Probiotic Compound VSL#3 Modulates Mucosal, Peripheral, and Systemic Immunity Following Murine Broad-Spectrum Antibiotic Treatment.
    Ekmekciu I; von Klitzing E; Fiebiger U; Neumann C; Bacher P; Scheffold A; Bereswill S; Heimesaat MM
    Front Cell Infect Microbiol; 2017; 7():167. PubMed ID: 28529928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestinal permeability, microbial translocation, changes in duodenal and fecal microbiota, and their associations with alcoholic liver disease progression in humans.
    Maccioni L; Gao B; Leclercq S; Pirlot B; Horsmans Y; De Timary P; Leclercq I; Fouts D; Schnabl B; Stärkel P
    Gut Microbes; 2020 Nov; 12(1):1782157. PubMed ID: 32588725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.